Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Aug 2021 for Theravance Biopharma, Inc., €52k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Bradford J. Shafer: trading record in brief
All filings by Bradford J. Shafer on record concern Theravance Biopharma, Inc., in the capacity of chief executive. In total, 2 filings cover trades dated from 20 May 2021 to 20 August 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 24 August 2021: a share grant of €52k, in Theravance Biopharma, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Bradford J. Shafer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
4,307 shares@ US$14.0545.2% of flowOrdinary SharesSEC:0001179110-21-008402:0
4,310 shares@ US$17.8054.8% of flowOrdinary SharesSEC:0001179110-21-005850:0
2 of 2 declarations
